McNerney, K. O., Si Lim, S. J., Ishikawa, K., Dreyzin, A., Vatsayan, A., Chen, J. J., Baggott, C., Prabhu, S., Pacenta, H. L., Philips, C., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Verneris, M., Myers, D., Karras, N. A., Brown, P., Bonifant, C. L., … Schultz, L. M. (2023). HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. Blood Advances, 7(12), 2758–2771. https://doi.org/10.1182/bloodadvances.2022008893

Afify, Z., Orjuela‐Grimm, M., Smith, C. M., Dalal, M., Ford, J. B., Pillai, P., Robles, J. M., Reddy, S., McCormack, S., Ehrhardt, M. J., Ureda, T., Alperstein, W., Edington, H., Miller, T. P., Rubinstein, J. D., Kavanaugh, M., Bukowinski, A. J., Friehling, E., Rivers, J. M., … Mason, C. C. (2022). Burkitt lymphoma after solid‐organ transplant: Treatment and outcomes in the paediatric PTLD collaborative. British Journal of Haematology, 200(3), 297–305. Portico. https://doi.org/10.1111/bjh.18498

El-Atoum, B., Williams, M., Molina, K., Orjuela-Grimm, M. A., Prince, J., & Afify, Z. (2021). Burkitt Lymphoma After Cardiac Transplantation: Therapeutic Considerations. Journal of Pediatric Hematology/Oncology, 44(3), 100–102. https://doi.org/10.1097/mph.0000000000002260